Evolution of kallikrein-related peptidases in mammals and identification of a genetic locus encoding potential regulatory inhibitors.
about
Novel expressed sequences identified in a model of androgen independent prostate cancer.The discovery of compounds that stimulate the activity of kallikrein-related peptidase 3 (KLK3).Prostate kallikrein markers in diagnosis, risk stratification and prognosis.Targeting free prostate-specific antigen for in vivo imaging of prostate cancer using a monoclonal antibody specific for unique epitopes accessible on free prostate-specific antigen aloneProstate-specific antigen (PSA) is activated by KLK2 in prostate cancer ex vivo models and in prostate-targeted PSA/KLK2 double transgenic mice.Quantitative DNA methylation analysis of genes coding for kallikrein-related peptidases 6 and 10 as biomarkers for prostate cancer.Clinical significance and novel mechanism of action of kallikrein 6 in glioblastoma.Proteomics and comparative genomic investigations reveal heterogeneity in evolutionary rate of male reproductive proteins in mice (Mus domesticus).Kininogen gene (KNG) variation has a consistent effect on aldosterone response to antihypertensive drug therapy: the GERA study.New insights into the functional mechanisms and clinical applications of the kallikrein-related peptidase family.Metastasis of ovarian cancer is mediated by kallikrein related peptidases.Kallikrein-related peptidases: bridges between immune functions and extracellular matrix degradation.Proteomic and other analyses to determine the functional consequences of deregulated kallikrein-related peptidase (KLK) expression in prostate and ovarian cancer.Tissue-specific promoter utilisation of the kallikrein-related peptidase genes, KLK5 and KLK7, and cellular localisation of the encoded proteins suggest roles in exocrine pancreatic function.Molecular cloning of novel transcripts of human kallikrein-related peptidases 5, 6, 7, 8 and 9 (KLK5 - KLK9), using Next-generation sequencing.
P2860
Q33270540-C954B427-2D4E-461A-976F-50D6442F2E45Q34033411-4FEF2C49-49D2-4E8B-A8AE-50C1BCE91029Q35683035-43D81BB9-B4B4-4D92-9D8B-7475B51588E5Q35964874-E06CB168-5142-4214-8CB7-564A3ED8A908Q36266738-553F5F22-576D-43C0-ACBA-91C449E27E79Q36447329-5137E371-6668-4A6A-92AD-1F3F7C4C882AQ36627182-A84B4226-DF1E-44CF-9906-EC3C52FBC6E6Q37324374-0CFDB9B5-5FCF-4F43-8BCB-6A2A754A769AQ37354446-6F3171D1-309A-4106-A51D-697D20481616Q37453804-3CEEA6A9-C8F9-4C6C-8304-C3881E67862BQ37480184-F6DC1E06-4105-4D9E-BD21-C15D317AD867Q37697808-1E09D0C3-A326-4963-8FB2-14CA92FB40A3Q38188878-AE2D85D8-3644-4F41-A46D-C7B93D262921Q46829746-20F8C2B7-4431-4542-A03A-7079013564B0Q47164608-8586EAED-F384-45F8-BF58-83027C09EAA8
P2860
Evolution of kallikrein-related peptidases in mammals and identification of a genetic locus encoding potential regulatory inhibitors.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Evolution of kallikrein-relate ...... tential regulatory inhibitors.
@ast
Evolution of kallikrein-relate ...... tential regulatory inhibitors.
@en
type
label
Evolution of kallikrein-relate ...... tential regulatory inhibitors.
@ast
Evolution of kallikrein-relate ...... tential regulatory inhibitors.
@en
prefLabel
Evolution of kallikrein-relate ...... tential regulatory inhibitors.
@ast
Evolution of kallikrein-relate ...... tential regulatory inhibitors.
@en
P2093
P2860
P356
P1433
P1476
Evolution of kallikrein-relate ...... tential regulatory inhibitors.
@en
P2093
A Yvonne Olsson
Adam Clauss
Ake Lundwall
P2860
P304
P356
10.1515/BC.2006.032
P577
2006-03-01T00:00:00Z